Advertisement Cielo MedSolutions gets STTR grant - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cielo MedSolutions gets STTR grant

Cielo MedSolutions has received a $1.3m Phase II Small Business Technology Transfer (STTR) grant from the National Cancer Institute (NCI), an institute of the National Institutes of Health to develop and prototype a clinical quality management solution based upon the company's product, Cielo Clinic.

Cielo chief medical officer Donald Nease said that in Phase I, they successfully studied and documented the needs and expectations of primary care practices and providers regarding web-based information technology for disease management and quality improvement.

"The episode-of-care data model used in building this system will be clinically-focused and this alone will allow us to create features not seen in other systems, the features we continually heard providers wanted," Nease said.

Cielo product and operations senior vice president Chris King said that their findings confirmed the need for a fresh approach to clinical technology in primary care medicine.

"In this Phase II, we will be building and prototyping the system that practices and providers said they wanted: a lightweight, web-delivered solution designed for all care-delivery participants that tracks and manages activities and outcomes at all stages including screening, prevention, diagnosis and treatment," King said.

"The system will also simultaneously support the requirements of Meaningful Use, patient-centered medical homes and pay-for-performance programs in an integrated manner."